Project Management for Pharmaceuticals

Venue: Caribe Royale

Location: Orlando, Florida, United States

Event Date/Time: Apr 26, 2004 End Date/Time: Apr 28, 2004
Report as Spam


The Institute for International Research is proud to present the second annual Sarbanes-Oxley and Compliance Conference for the pharmaceutical and biotech industries. The Sarbanes-Oxley Act of 2002 was passed in the wake of Enron and other corporate accounting scandals to prevent ethics scandals and other governance problems from recurring and to rebuild public trust in corporate business and reporting practices. Publicly traded corporations and heavily regulated industries such as the pharmaceutical industry are affected most. In July of 2003, IIR provided the first conference to answer pharmaceutical and biotech companies’ questions surrounding Sarbanes-Oxley and its impact. Our 2004 May event answers the next level of Sarbanes-Oxley questions and helps you sustain and improve your overall compliance strategy.

The new Act is dramatically altering the legal and compliance landscape for the pharmaceutical industry and guidance is needed for success. The objective of our three-day conference is to propose tools and strategies, along with implementation procedures, to ensure drug companies achieve Sarbanes-Oxley compliance. In addition, we arm you with strategies to expand compliance programs beyond Sarbanes-Oxley. Whether you are a CEO, CFO, COO, Ethics/Corporate Compliance Officer, Director of Finance/Accounting, Tax Economist or Corporate Counsel, you play a pivotal role in meeting your company’s and the federal government’s compliance regulations. As the debate over corporate compliance and good corporate practices continues, the Sarbanes-Oxley legislation requires major structural changes and procedural changes to your business practice. This forum brings together key players to share solutions and meet Sarbanes-Oxley and compliance requirements.

Shape of the Agenda

On Day One (Wednesday, May 12) of the conference, extend your compliance and SOX education by participating in the preconference workshops. The morning workshop covers Contract and Rebate Operations - Developing Seamless Reporting and An Effective Control Process to Meet Section 404 Requirements. The afternoon workshop offers A Solution for Sarbanes-Oxley and Enterprise-Wide Governance, Risk and Compliance Management. By attending the morning workshop, you learn strategies to take back to your own compliance and contract operations departments to address the requirements of Section 404. In the afternoon workshop, you gain the knowledge of how to leverage Sarbanes-Oxley compliance efforts into your overall business performance, by improving business processes and addressing compliance issues impacting other areas of your business.

Day Two (Thursday, May 13) of the conference kicks off our main agenda, focused on Sarbanes-Oxley compliance. We start out the day with a featured presentation given by John Hagerty from AMR on emerging best practices and benchmarks for Sarbanes-Oxley Compliance. On Thursday, hear presentations given by Eli Lilly, Miller & Chevalier Chartered, IRS, PCAOB, Novartis, Pepper Hamilton, ISIS Pharmaceuticals and Marsh Group.

On the last day of the conference (Friday, May 14), we open with our final featured presentation discussion from Carol Rozwell, Vice President and Research Director, Life Sciences for Gartner Group discussing complying with new regulatory compliance...beyond SOX. Next you hear from Barsh Consultancy, Hyman, Phelps & McNamara, Pfizer, Axentis, Deloitte, SEC and Epstein Becker & Green.

Key Opportunity to Network

Meet our distinguished speaking faculty during coffee and refreshment breaks, as well as luncheons, panel discussions and Q&A sessions. Don’t miss this unique opportunity to talk one-on-one with our speaking facility and meet with industry colleagues. In addition to these networking opportunities, you receive a copy of the conference documentation, a valuable tool to take back to your office for future reference.